Abrogation of the Chk1-mediated G2 checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells

Y. Hirose, M. S. Berger, R. O. Pieper

Research output: Contribution to journalArticle

198 Citations (Scopus)

Fingerprint Dive into the research topics of 'Abrogation of the Chk1-mediated G<sub>2</sub> checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells'. Together they form a unique fingerprint.

Medicine & Life Sciences